Citi analyst Mathieu Chevrier downgraded Fisher & Paykel Healthcare to Neutral from Buy with a NZ$28.75 price target. The analyst cites valuation for the downgrade.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on FSPKF:
